Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia
Hanan Ehtewish, Areej G. Mesleh, Georgios Ponirakis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8117-8117
Open Access | Times Cited: 12

Showing 12 citing articles:

Alzheimer’s disease early diagnostic and staging biomarkers revealed by large-scale cerebrospinal fluid and serum proteomic profiling
Qing‐Qing Tao, Xue Cai, Yan‐Yan Xue, et al.
The Innovation (2024) Vol. 5, Iss. 1, pp. 100544-100544
Open Access | Times Cited: 22
The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization
Amanda M. Leisgang Osse, Jefferson W. Kinney, Jeffrey L. Cummings
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Plasma Proteomic Signature as a Predictor of Age Advancement in People Living With HIV
Adriana Navas, Vasiliki Matzaraki, Louise E. van Eekeren, et al.
Aging Cell (2025)
Open Access
Identification of Blood Plasma Protein Ratios for Distinguishing Alzheimer's Disease from Healthy Controls Using Machine Learning
Ali Safi, Elisa Giunti, Omar Melikechi, et al.
Heliyon (2025), pp. e42349-e42349
Open Access
Biomarker Profile in Peripheral Blood Cells Related to Alzheimer’s Disease
Mirko Lomi, Filippo Geraci, Cristina Del Seppia, et al.
Molecular Neurobiology (2025)
Open Access
Identification and Exploration of Immunity‐Related Genes and Natural Products for Alzheimer's Disease Based on Bioinformatics, Molecular Docking, and Molecular Dynamics
Pengpeng Liang, Chang Ye Yale Wang, J Liu, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 4
Open Access
Plasma proteomics and lipidomics facilitate elucidation of the link between Alzheimer's disease development and vessel wall fragility
Suzumi M. Tokuoka, Fumie Hamano, Ayako Kobayashi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Biological gases, oxidative stress, artificial intelligence, and machine learning for neurodegeneration and metabolic disorders
Kenneth Maiese
Medical Gas Research (2024) Vol. 15, Iss. 1, pp. 145-147
Closed Access | Times Cited: 2
Angiotensin-converting enzyme inhibitors and statins therapies-induced changes in omics profiles in humans and transgenic tau mice
Roberto Collu, Elisa Giunti, Sarah Daley, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115756-115756
Open Access | Times Cited: 4
Artificial Intelligence and Disease Signature Pathways: Driving Innovation to Elucidate Underlying Pathogenic Mechanisms
Kenneth Maiese
Current Neurovascular Research (2024) Vol. 21, Iss. 3, pp. 229-233
Closed Access | Times Cited: 1
Migraine Disorders, Neurovascular Disease, and the Underlying Role of Oxidative Stress
Kenneth Maiese
Current Neurovascular Research (2024) Vol. 21, Iss. 2, pp. 111-115
Closed Access
Molecular Mechanisms Underlying Chronic and Degenerative Diseases
Alessandro Cannavò
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12507-12507
Open Access | Times Cited: 1
Page 1

Scroll to top